These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 22400811

  • 1. Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.
    Duan Z, Li X, Huang H, Yuan W, Zheng SL, Liu X, Zhang Z, Choy E, Harmon D, Mankin H, Hornicek F.
    J Med Chem; 2012 Apr 12; 55(7):3113-21. PubMed ID: 22400811
    [Abstract] [Full Text] [Related]

  • 2. NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo.
    Yang X, Feng Y, Gao Y, Shen J, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z.
    Gynecol Oncol; 2015 Apr 12; 137(1):134-42. PubMed ID: 25677062
    [Abstract] [Full Text] [Related]

  • 3. Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.
    Yang X, Shen J, Gao Y, Feng Y, Guan Y, Zhang Z, Mankin H, Hornicek FJ, Duan Z.
    Int J Cancer; 2015 Oct 15; 137(8):2029-39. PubMed ID: 25904021
    [Abstract] [Full Text] [Related]

  • 4. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 15; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X, Sui M, Fan W.
    Anticancer Res; 2005 Nov 15; 25(3B):1953-62. PubMed ID: 16158930
    [Abstract] [Full Text] [Related]

  • 6. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X, Lu WL, Liang GW, Ruan GR, Hong HY, Long C, Zhang YT, Liu Y, Wang JC, Zhang X, Zhang Q.
    Eur J Clin Invest; 2006 Jun 15; 36(6):409-18. PubMed ID: 16684125
    [Abstract] [Full Text] [Related]

  • 7. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
    Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z.
    J Biomol Screen; 2010 Mar 15; 15(3):287-96. PubMed ID: 20150589
    [Abstract] [Full Text] [Related]

  • 8. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 9. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW, Lu WL, Wu JW, Zhao JH, Hong HY, Long C, Li T, Zhang YT, Zhang H, Wang JC, Zhang X, Zhang Q.
    Fundam Clin Pharmacol; 2008 Aug 21; 22(4):429-37. PubMed ID: 18705753
    [Abstract] [Full Text] [Related]

  • 10. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.
    Yang X, Yang P, Shen J, Osaka E, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z.
    Br J Cancer; 2014 Jun 10; 110(12):2896-904. PubMed ID: 24853187
    [Abstract] [Full Text] [Related]

  • 11. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
    Naito M, Matsuba Y, Sato S, Hirata H, Tsuruo T.
    Clin Cancer Res; 2002 Feb 10; 8(2):582-8. PubMed ID: 11839680
    [Abstract] [Full Text] [Related]

  • 12. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators.
    Shen X, Chen G, Zhu G, Cai J, Wang L, Hu Y, Fong WF.
    J Pharm Pharmacol; 2012 Jan 10; 64(1):90-100. PubMed ID: 22150676
    [Abstract] [Full Text] [Related]

  • 13. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA, Nervi AM, Anthony SP, Kaltreider RC, Warren AJ, Pesce CA, Davis SA, Lariviere JP, Hamilton JW.
    Oncol Res; 1999 Jan 10; 11(7):303-10. PubMed ID: 10757444
    [Abstract] [Full Text] [Related]

  • 14. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb 10; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
    Lee BD, Li Z, French KJ, Zhuang Y, Xia Z, Smith CD.
    J Med Chem; 2004 Mar 11; 47(6):1413-22. PubMed ID: 14998330
    [Abstract] [Full Text] [Related]

  • 16. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD.
    Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D, Dekel Y, Melikhov D, Margalit R.
    Cancer Res; 2004 Oct 15; 64(20):7562-9. PubMed ID: 15492283
    [Abstract] [Full Text] [Related]

  • 18. NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.
    Duan Z, Choy E, Hornicek FJ.
    PLoS One; 2009 Oct 12; 4(10):e7415. PubMed ID: 19823672
    [Abstract] [Full Text] [Related]

  • 19. Reversal of multidrug resistance in vitro and in vivo by 5-N-formylardeemin, a new ardeemin derivative.
    Zheng X, Li D, Zhao C, Wang Q, Song H, Qin Y, Liao L, Zhang L, Lin Y, Wang X.
    Apoptosis; 2014 Aug 12; 19(8):1293-300. PubMed ID: 24858827
    [Abstract] [Full Text] [Related]

  • 20. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 12; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.